About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
Symbol
Name
ID 		Slc18a2
solute carrier family 18 (vesicular monoamine), member 2
MGI:106677
60 phenotypes from 6 alleles in 7 genetic backgrounds
Export: Excel File
Allelic Composition
Genetic Background		 Annotated Term Reference
Slc18a2tm1.1Bgir/Slc18a2tm1.1Bgir
Slc6a4tm1(cre)Xz/Slc6a4+
involves: 129S1/Sv * C57BL/6J 		abnormal catecholamine level J:197966
abnormal emotion/affect behavior J:197966
decreased anxiety-related response J:197966
decreased locomotor activity J:197966
decreased serotonin level J:197966
normal nervous system phenotype J:197966
postnatal lethality, incomplete penetrance J:197966
Slc18a2tm1Edw/Slc18a2+
involves: 129X1/SvJ * C57BL/6 		abnormal noradrenaline level J:45183
abnormal serotonin level J:45183
decreased dopamine level J:45183
Slc18a2tm1Edw/Slc18a2tm1Edw
involves: 129X1/SvJ 		abnormal dopaminergic neuron morphology J:96932
abnormal neurotransmitter secretion J:96932
abnormal synaptic vesicle morphology J:96932
decreased dopamine level J:96932
Slc18a2tm1Edw/Slc18a2tm1Edw
involves: 129X1/SvJ * C57BL/6 		abnormal neurotransmitter secretion J:45183
abnormal noradrenaline level J:45183
abnormal serotonin level J:45183
absent gastric milk in neonates J:45183
bradykinesia J:45183
decreased body size J:45183
decreased body weight J:45183
decreased dopamine level J:45183
postnatal lethality, complete penetrance J:45183
Slc18a2tm1Kmo/Slc18a2tm1Kmo
involves: 129P2/OlaHsd * C57BL/6 		neonatal lethality, complete penetrance J:70606
Slc18a2tm1Mca/Slc18a2+
B6.129X1-Slc18a2tm1Mca 		abnormal associative learning J:125273
abnormal corticosterone level J:125273
abnormal liquid preference J:125273
normal behavior/neurological phenotype J:125273
decreased coping response J:125273
decreased locomotor activity J:125273
decreased vertical activity J:125273
enhanced long-term potentiation J:89778
Slc18a2tm1Mca/Slc18a2+
involves: 129X1/SvJ 		abnormal neurotransmitter secretion J:45184
abnormal neurotransmitter uptake J:45184
decreased dopamine level J:45184
decreased physiological sensitivity to xenobiotic J:45184
enhanced behavioral response to addictive substance J:45184
impaired behavioral response to cocaine J:45184
Slc18a2tm1Mca/Slc18a2+
involves: 129X1/SvJ * C57BL/6J 		abnormal liquid preference J:124481
normal behavior/neurological phenotype J:124481
decreased alcohol consumption J:124481
impaired conditioned place preference behavior J:124481
Slc18a2tm1Mca/Slc18a2tm1Mca
involves: 129X1/SvJ 		abnormal dopamine level J:45184
abnormal enzyme/coenzyme activity J:45184
abnormal synaptic neurotransmitter level J:45184
decreased birth body size J:45184
decreased body temperature J:45184
decreased locomotor activity J:45184
postnatal growth retardation J:45184
postnatal lethality, complete penetrance J:45184
Slc18a2tm1Uhl/Slc18a2+
involves: 129S7/SvEvBrd * C57BL/6J 		enhanced behavioral response to addictive substance J:42811
impaired conditioned place preference behavior J:42811
increased susceptibility to dopaminergic neuron neurotoxicity J:42811
premature death J:42811, J:57671
prolonged QT interval J:57671
Slc18a2tm1Uhl/Slc18a2tm1Uhl
involves: 129S7/SvEvBrd * C57BL/6J 		neonatal lethality, incomplete penetrance J:42811
postnatal lethality, complete penetrance J:42811
Slc18a2tm2Kmo/Slc18a2tm2Kmo
involves: 129P2/OlaHsd * C57BL/6 		abnormal circadian behavior J:150414
abnormal emotion/affect behavior J:150414
abnormal motor capabilities/coordination/movement J:150414
abnormal nervous system physiology J:150414
abnormal noradrenaline level J:70606, J:150414
abnormal response to new environment J:70606
abnormal response to novel odor J:150414
abnormal response to novelty J:150414
abnormal sleep pattern J:150414
alpha-synuclein inclusion body J:123245
decreased body weight J:70606
decreased coping response J:150414
decreased dopamine level J:70606, J:123245, J:150414
decreased dopaminergic neuron number J:123245
decreased locomotor activity J:123245, J:150414
decreased serotonin level J:70606, J:150414
impaired coordination J:70606
impaired gastric peristalsis J:150414
impaired olfaction J:150414
increased anxiety-related response J:150414
increased defecation amount J:150414
increased susceptibility to dopaminergic neuron neurotoxicity J:70606
normal muscle phenotype J:150414
neuron degeneration J:123245
stereotypic behavior J:70606
normal vision/eye phenotype J:150414
Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
11/12/2024
MGI 6.24 		The Jackson Laboratory